Saturday, November 15, 2025

Diabetes Mellitus (DM)

Diabetes Mellitus (DM)


1. INTRODUCTION

Diabetes Mellitus (DM) is a chronic metabolic disease characterized by persistent hyperglycemia.
Hyperglycemia means abnormally high glucose levels in blood, usually because of:

  1. Impaired insulin secretion (pancreas not producing enough insulin)
  2. Impaired insulin action (body cells not responding to insulin – called insulin resistance)
  3. Both combined

Diabetes is a multisystem disorder affecting blood vessels, nerves, kidneys, eyes, heart, and immunity.


2. NORMAL PHYSIOLOGY OF GLUCOSE REGULATION

2.1 Pancreatic Structure & Insulin Synthesis

Pancreas has clusters of endocrine cells called Islets of Langerhans:

  • β-cells (beta cells) – produce insulin
  • α-cells (alpha cells) – produce glucagon
  • δ-cells (delta cells) – produce somatostatin
  • PP cells – produce pancreatic polypeptide

Insulin is synthesized as: Preproinsulin → Proinsulin → Insulin + C-peptide

C-peptide reflects the body’s natural insulin production.


2.2 Mechanism of Insulin Secretion

Insulin release occurs when blood glucose rises after a meal.

Sequence:

  1. Glucose enters β-cells via GLUT-2 transporter
  2. Glucose undergoes metabolism → increases ATP
  3. ATP closes K⁺ channels on β-cell membrane
  4. Cell depolarizes → Calcium enters
  5. Insulin-containing vesicles fuse → Insulin is released into blood

2.3 Actions of Insulin

Insulin is an anabolic hormone (builds tissues).

Effects on major tissues

Liver

  • Inhibits gluconeogenesis (producing glucose from non-carbohydrate sources)
  • Inhibits glycogenolysis (breakdown of glycogen)
  • Promotes glycogenesis (formation of glycogen)
  • Promotes lipogenesis (fat formation)

Muscle

  • Increases GLUT-4 translocation → more glucose uptake
  • Increases protein synthesis

Adipose tissue

  • Promotes fat storage
  • Inhibits lipolysis (breakdown of fat)

2.4 Role of Glucagon

Secreted when blood sugar falls.

Actions:

  • Stimulates glycogenolysis
  • Stimulates gluconeogenesis
  • Raises blood glucose levels

Thus, INSULIN and GLUCAGON work as a balanced system.


3. PATHOPHYSIOLOGY OF DIABETES MELLITUS

3.1 Type 1 Diabetes Mellitus (T1DM)

Autoimmune destruction of β-cells → absolute insulin deficiency.

Mechanisms:

  • Immune system produces autoantibodies against β-cell antigens
  • Gradual β-cell destruction
  • No insulin → glucose cannot enter cells → severe hyperglycemia

Common before age 20, but may occur anytime.

Clinical signs:

  • Sudden weight loss
  • Polyuria (excess urination)
  • Polydipsia (excess thirst)
  • Polyphagia (excess hunger)
  • Diabetic ketoacidosis (DKA)

3.2 Type 2 Diabetes Mellitus (T2DM)

Most common type.
Characterized by:

  1. Insulin resistance – cells do not respond to insulin
  2. β-cell dysfunction – gradual decline in insulin production

Causes:

  • Obesity
  • Abdominal fat (visceral fat)
  • Physical inactivity
  • Genetics
  • Chronic inflammation

Mechanisms:

Insulin receptor signaling fails → GLUT-4 fails to move → glucose cannot enter cells
• Liver continues producing glucose even when blood sugar is already high
• Pancreas tries to compensate → hyperinsulinemia
• β-cells eventually fatigue → insulin levels fall


3.3 Gestational Diabetes Mellitus (GDM)

Diabetes first detected during pregnancy.

Mechanism:

  • Pregnancy hormones (human placental lactogen, estrogen, progesterone) cause insulin resistance
  • Pancreas cannot compensate → hyperglycemia

3.4 Secondary Diabetes

Due to:

  • Pancreatic diseases (pancreatitis, pancreatic cancer)
  • Endocrine excess (Cushing’s, acromegaly)
  • Drugs (steroids, antipsychotics)
  • Genetic disorders

4. WHY DOES HYPERGLYCEMIA DAMAGE ORGANS?

(Pathogenesis of Complications)**

Chronic hyperglycemia leads to:

4.1 Advanced Glycation End Products (AGEs)

High glucose attaches to proteins → forms AGEs
These cause:

  • Vessel wall thickening
  • Inflammation
  • Oxidative stress

4.2 Polyol Pathway Activation

Glucose converted into sorbitol
Sorbitol accumulates → cell swelling → nerve & lens damage
→ leads to neuropathy and cataracts


4.3 Protein Kinase C Activation

Causes:

  • Vasoconstriction
  • Retinal damage
  • Renal damage

4.4 Oxidative Stress

Excess glucose produces free radicals
Damages:

  • Endothelium
  • DNA
  • Mitochondria

5. CLINICAL FEATURES OF DIABETES

5.1 Classic Features

  • Polyuria
  • Polydipsia
  • Polyphagia
  • Weight loss (mainly in T1DM)
  • Fatigue
  • Blurred vision
  • Recurrent infections

5.2 Complications

Acute

  • DKA (ketoacidosis)
  • HHS (hyperosmolar hyperglycemic state)
  • Severe hypoglycemia

Chronic

Microvascular:

  • Retinopathy
  • Nephropathy
  • Neuropathy

Macrovascular:

  • Coronary artery disease
  • Stroke
  • Peripheral vascular disease

6. INVESTIGATIONS IN DIABETES

6.1 Blood Glucose Tests

Fasting Plasma Glucose (FPG)

Measured after 8 hours of fasting.
High fasting glucose = impaired hepatic glucose regulation.


Postprandial Plasma Glucose (PPG)

Measured 2 hours after food.
Reflects ability of pancreas to handle a glucose load.


Random Plasma Glucose

Useful for symptomatic patients.


6.2 Oral Glucose Tolerance Test (OGTT)

Patient drinks 75 g glucose.
Blood glucose measured fasting & after 2 hours.
Shows how efficiently the body clears glucose.


6.3 HbA1c (Glycated Hemoglobin)

Represents average blood glucose for last 3 months.

Mechanism: Glucose binds to hemoglobin in RBCs → forms HbA1c
Higher glucose = higher HbA1c

Useful for diagnosis and monitoring.


6.4 Urine Investigations

Urine glucose

Appears when blood sugar > renal threshold (180 mg/dL)

Urine ketones

Indicates fat breakdown; important in suspected DKA.

Microalbuminuria

Very early marker of diabetic kidney disease.


6.5 Tests for Complications

Kidney

  • Serum creatinine
  • eGFR
  • Urine albumin-creatinine ratio

Eyes

  • Fundus examination
  • OCT (when needed)

Nerves

  • Monofilament test
  • Vibration sense
  • Nerve conduction studies (advanced)

Cardiovascular

  • Lipid profile
  • ECG
  • Carotid Doppler (if needed)

6.6 Immunological Tests (Type 1 DM)

Presence of autoantibodies:

  • GAD (Glutamic acid decarboxylase) antibody
  • IA-2 antibody
  • ZnT8 antibody
  • Islet cell antibody (ICA)

These confirm autoimmune destruction of β-cells.


7. DIABETIC KETOACIDOSIS (DKA) – PATHOPHYSIOLOGY IN SIMPLE TERMS

Occurs mainly in Type 1 diabetes.

Sequence:

  1. No insulin → cells cannot take up glucose
  2. Body thinks it is starving → breaks fat rapidly
  3. Fat breakdown produces ketone bodies
  4. Ketones accumulate → blood becomes acidic
  5. Dehydration + acidosis = dangerous, life-threatening condition

Clinical features:
Fruity breath, Kussmaul breathing, abdominal pain, vomiting.


8. HYPEROSMOLAR HYPERGLYCEMIC STATE (HHS)

Typical of T2DM in elderly.

Mechanism:

  • Severe hyperglycemia
  • Extreme dehydration
  • No significant ketoacidosis

Very high mortality.


9. SUMMARY  

Diabetes = chronic hyperglycemia due to insulin defect.
Type 1 = absolute insulin deficiency.
Type 2 = insulin resistance + β-cell failure.
Chronic high glucose causes vascular, neural, renal & retinal damage.
Diagnosis uses FPG, PPG, OGTT, HbA1c.
Monitoring includes checking for kidney, eye, nerve & heart involvement.



No comments:

Post a Comment

COMPREHENSIVE CASE SHEET FOR ALL SYSTEM DISORDERS

SECTION 1: IDENTIFICATION DATA □ Name □ Age □ Sex □ Hospital Registration Number □ IP / OP Number □ Date and Time of Registration □ Date and...